EUVIMEDEUVIMED entdecken
Crossref

Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells

Nitika Sharma, Swarbhanu Sarkar, Jean M Etersque, Kimberly J Edwards, Jonathan M Pham, Kexiang Xu, Joshua Scheuermann, Tommy Nguyen, Andrew Ruff, Paul Martorano, Justin D Northrup, Katheryn Lohith und 4 weitere

Journal of Nuclear Medicine · 06.08.2026 · jnumed.126.272322

DOI: 10.2967/jnumed.126.272322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 06.08.2026. Verfasst von Nitika Sharma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Trimethoprim, Tetrahydrofolate Dehydrogenase, Escherichia coli. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesTrimethoprimTetrahydrofolate DehydrogenaseEscherichia coliTheranostic NanomedicineGenetic EngineeringAnimalsMiceHumansTissue DistributionRadiopharmaceuticalsCell Line, Tumor

Stichwörter der Autor:innen

RPTgene therapyradiopharmaceutical therapytheranostics

Substanzen

Iodine RadioisotopesTrimethoprimTetrahydrofolate DehydrogenaseRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.
  • Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and mark.sellmyer@pennmedicine.upenn.edu.
  • Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania.

Zitieren

APA

Sharma, N., Sarkar, S., Etersque, J. M., Edwards, K. J., Pham, J. M., Xu, K., Scheuermann, J., Nguyen, T., Ruff, A., Martorano, P., Northrup, J. D., Lohith, K., Lee, H. S., Farwell, M. D., Pryma, D., & Sellmyer, M. A. (2026). Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells. Journal of Nuclear Medicine, jnumed.126.272322. https://doi.org/10.2967/jnumed.126.272322

Vancouver

Sharma N, Sarkar S, Etersque JM, Edwards KJ, Pham JM, Xu K, et al. Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells. Journal of Nuclear Medicine. 2026:jnumed.126.272322. doi:10.2967/jnumed.126.272322

BibTeX
@article{Sharma2026,
  author = {Sharma, Nitika and Sarkar, Swarbhanu and Etersque, Jean M and Edwards, Kimberly J and Pham, Jonathan M and Xu, Kexiang and Scheuermann, Joshua and Nguyen, Tommy and Ruff, Andrew and Martorano, Paul and Northrup, Justin D and Lohith, Katheryn and Lee, Hsiaoju S and Farwell, Michael D and Pryma, Daniel and Sellmyer, Mark A},
  title = {Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  pages = {jnumed.126.272322},
  doi = {10.2967/jnumed.126.272322}
}
Kostenlos starten →